Patients 0 8 0 8 O
may 9 12 9 12 O
enroll 13 19 13 19 O
with 20 24 20 24 O
recently 25 33 25 33 O
( 34 35 34 35 O
with 35 39 35 39 O
2 40 41 40 41 B-upper_bound
months 42 48 42 48 I-upper_bound
) 48 49 48 49 O
progressive 50 61 50 61 O
tumor 62 67 62 67 B-cancer
burden 68 74 68 74 O

Patients 0 8 75 83 O
on 9 11 84 86 O
treatment 12 21 87 96 O
dose 22 26 97 101 O
anticoagulation 27 42 102 117 B-treatment
or 43 45 118 120 O
an 46 48 121 123 O
International 49 62 124 137 B-clinical_variable
Normalised 63 73 138 148 I-clinical_variable
Ratio 74 79 149 154 I-clinical_variable
of 80 82 155 157 O
2 83 84 158 159 O
or 85 87 160 162 O
greater 88 95 163 170 O
if 96 98 171 173 O
on 99 101 174 176 O
warfarin 102 110 177 185 B-treatment

Patients 0 8 186 194 O
who 9 12 195 198 O
are 13 16 199 202 O
known 17 22 203 208 O
to 23 25 209 211 O
be 26 28 212 214 O
pregnant 29 37 215 223 B-pregnancy

Patients 0 8 224 232 O
with 9 13 233 237 O
active 14 20 238 244 O
, 20 21 244 245 O
uncontrolled 22 34 246 258 O
coagulopathy 35 47 259 271 B-chronic_disease

Patients 0 8 272 280 O
with 9 13 281 285 O
metastatic 14 24 286 296 B-cancer
breast 25 31 297 303 I-cancer
cancer 32 38 304 310 I-cancer

Performance 0 11 311 322 B-clinical_variable
status 12 18 323 329 I-clinical_variable
of 19 21 330 332 O
0,1 22 25 333 336 B-lower_bound
or 26 28 337 339 O
2 29 30 340 341 B-upper_bound

age 0 3 342 345 B-age
21 4 6 346 348 B-lower_bound
or 7 9 349 351 O
older 10 15 352 357 O

